Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

The contribution of CNVs to the most common aging-related neurodegenerative diseases.

Gentile G, La Cognata V, Cavallaro S.

Aging Clin Exp Res. 2020 Feb 6. doi: 10.1007/s40520-020-01485-4. [Epub ahead of print] Review.

PMID:
32026430
2.

Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions.

La Cognata V, Gentile G, Aronica E, Cavallaro S.

Cells. 2020 Jan 8;9(1). pii: E159. doi: 10.3390/cells9010159.

3.

Translational Medicine in Neurological Disorders: A Genomic Perspective.

Gentile G, Cavallaro S.

Curr Genomics. 2019 Apr;20(3):151-153. doi: 10.2174/138920292003190704143857. No abstract available.

4.

Dental mesenchymal stem cells and neuro-regeneration: a focus on spinal cord injury.

Bonaventura G, Incontro S, Iemmolo R, La Cognata V, Barbagallo I, Costanzo E, Barcellona ML, Pellitteri R, Cavallaro S.

Cell Tissue Res. 2020 Mar;379(3):421-428. doi: 10.1007/s00441-019-03109-4. Epub 2019 Nov 27. Review.

PMID:
31776822
5.

Deletion of Voltage-Dependent Anion Channel 1 knocks mitochondria down triggering metabolic rewiring in yeast.

Magrì A, Di Rosa MC, Orlandi I, Guarino F, Reina S, Guarnaccia M, Morello G, Spampinato A, Cavallaro S, Messina A, Vai M, De Pinto V.

Cell Mol Life Sci. 2019 Oct 26. doi: 10.1007/s00018-019-03342-8. [Epub ahead of print]

PMID:
31655859
6.

Biocompatibility between Silicon or Silicon Carbide surface and Neural Stem Cells.

Bonaventura G, Iemmolo R, La Cognata V, Zimbone M, La Via F, Fragalà ME, Barcellona ML, Pellitteri R, Cavallaro S.

Sci Rep. 2019 Aug 8;9(1):11540. doi: 10.1038/s41598-019-48041-3.

7.

Alternative Splicing of ALS Genes: Misregulation and Potential Therapies.

Perrone B, La Cognata V, Sprovieri T, Ungaro C, Conforti FL, Andò S, Cavallaro S.

Cell Mol Neurobiol. 2020 Jan;40(1):1-14. doi: 10.1007/s10571-019-00717-0. Epub 2019 Aug 5. Review.

PMID:
31385134
8.

A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.

Naimo GD, Guarnaccia M, Sprovieri T, Ungaro C, Conforti FL, Andò S, Cavallaro S.

Int J Mol Sci. 2019 Jul 30;20(15). pii: E3717. doi: 10.3390/ijms20153717. Review.

9.

Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS.

Morello G, Guarnaccia M, Spampinato AG, Salomone S, D'Agata V, Conforti FL, Aronica E, Cavallaro S.

Sci Rep. 2019 Jul 10;9(1):9968. doi: 10.1038/s41598-019-46355-w.

10.

Involvement of A3 Adenosine Receptor in Neuroblastoma Progression via Modulation of the Hypoxic/Angiogenic Pathway.

Maugeri G, D'Amico AG, Federico C, Saccone S, Giunta S, Cavallaro S, D'Agata V.

J Mol Neurosci. 2019 Sep;69(1):166-176. doi: 10.1007/s12031-019-01346-4. Epub 2019 Jun 5.

PMID:
31166001
11.

A novel S379A TARDBP mutation associated to late-onset sporadic ALS.

Sprovieri T, Ungaro C, Perrone B, Naimo GD, Spataro R, Cavallaro S, La Bella V, Conforti FL.

Neurol Sci. 2019 Oct;40(10):2111-2118. doi: 10.1007/s10072-019-03943-y. Epub 2019 Jun 4.

PMID:
31165305
12.

Histaminergic transmission slows progression of amyotrophic lateral sclerosis.

Apolloni S, Amadio S, Fabbrizio P, Morello G, Spampinato AG, Latagliata EC, Salvatori I, Proietti D, Ferri A, Madaro L, Puglisi-Allegra S, Cavallaro S, Volonté C.

J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):872-893. doi: 10.1002/jcsm.12422. Epub 2019 Apr 24.

13.

Clinical features and genetic analysis of two siblings with startle disease in an Italian family: a case report.

Sprovieri T, Ungaro C, Sivo S, Quintiliani M, Contaldo I, Veredice C, Citrigno L, Muglia M, Cavalcanti F, Cavallaro S, Mercuri E, Battaglia D.

BMC Med Genet. 2019 Mar 12;20(1):40. doi: 10.1186/s12881-019-0779-x.

14.

Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.

Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G; ITALSGEN Consortium; International ALS Genomics Consortium, Tienari PJ, Stone DJ, Nalls MA, Singleton AB, Chiò A, Traynor BJ.

Ann Neurol. 2019 Apr;85(4):470-481. doi: 10.1002/ana.25431. Epub 2019 Mar 13.

15.

A Genomic and Epigenomic Approach for Studying Neuropsychiatric Disorders Associated to Early-life Stress: Part II.

Pappalardo XG, Cavallaro S.

Curr Genomics. 2018 Dec;19(8):637. No abstract available.

16.

Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare.

Al-Mahdawi S, Ging H, Bayot A, Cavalcanti F, La Cognata V, Cavallaro S, Giunti P, Pook MA.

Front Cell Neurosci. 2018 Nov 21;12:443. doi: 10.3389/fncel.2018.00443. eCollection 2018.

17.

Editorial: A Genomic and Epigenomic Approach for Studying Neuropsychiatric Disorders Associated to Early-life Stress: Part I.

Pappalardo XG, Cavallaro S.

Curr Genomics. 2018 Nov;19(7):505-506. doi: 10.2174/138920291907180808105035. No abstract available.

18.

Taxonomy Meets Neurology, the Case of Amyotrophic Lateral Sclerosis.

Morello G, Spampinato AG, Conforti FL, Cavallaro S.

Front Neurosci. 2018 Sep 26;12:673. doi: 10.3389/fnins.2018.00673. eCollection 2018.

19.

ALS and CHARGE syndrome: a clinical and genetic study.

Ungaro C, Citrigno L, Trojsi F, Sprovieri T, Gentile G, Muglia M, Monsurrò MR, Tedeschi G, Cavallaro S, Conforti FL.

Acta Neurol Belg. 2018 Dec;118(4):629-635. doi: 10.1007/s13760-018-1029-2. Epub 2018 Oct 13.

20.

NeuroArray, A Custom CGH Microarray to Decipher Copy Number Variants in Alzheimer's Disease.

Cuccaro D, Guarnaccia M, Iemmolo R, D'Agata V, Cavallaro S.

Curr Genomics. 2018 Sep;19(6):499-504. doi: 10.2174/1389202919666180122141425.

Supplemental Content

Loading ...
Support Center